Post‐COVID‐19 co‐morbidity of emerged <i>Lophomonas</i> infection and invasive pulmonary aspergillosis: First case report - Concepedia

Concepedia

Publication | Open Access

Post‐COVID‐19 co‐morbidity of emerged <i>Lophomonas</i> infection and invasive pulmonary aspergillosis: First case report

DOI Full Paper Access

17

Citations

10

References

2021

Year

Ali Sharifpour, Zakaria Zakariaei, Mahdi Fakhar, Elham Sadat Banimostafavi, Maryam Nakhaei, Mostafa Soleymani

Clinical Case Reports

Abstract

Due to long corticosteroid therapy in patients with COVID-19, in case of cough, dyspnea, and weight loss, emerging pulmonary aspergillosis and lophomoniasis should be ruled out.

References

	Year	Citations

Page 1